Aptus Pharma (BOM:544529) EPS (Basic): ₹3.06 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544529 Aptus Pharma Ltd BOM:544529
18 GF Score
Price ₹278.50
! 6 Warning Signs
View Full Analysis

What is Aptus Pharma EPS (Basic)?

Aptus Pharma BOM:544529 +3.34% 18 EPS (Basic) is ₹3.06 as of Mar. 2026. GuruFocus rates BOM:544529 with a GF Score™ of 18/100. The stock has 6 warning signs investors should review.

Aptus Pharma's basic earnings per share (Basic EPS) for the six months ended in Mar. 2026 was ₹1.68. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹3.06.

Aptus Pharma's EPS (Diluted) for the six months ended in Mar. 2026 was ₹1.68. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹3.06.

Aptus Pharma's EPS without NRI for the six months ended in Mar. 2026 was ₹1.68. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 3.06.

During the past 12 months, Aptus Pharma's average EPS without NRIGrowth Rate was 72.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was 202.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, Aptus Pharma's highest 3-Year average EPS without NRI Growth Rate was 202.00% per year. The lowest was 202.00% per year. And the median was 202.00% per year.

Aptus Pharma  (BOM:544529) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Aptus Pharma EPS (Basic) Related Terms

Aptus Pharma EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Aptus Pharma's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aptus Pharma EPS (Basic) Chart

Aptus Pharma Annual Data
Trend Mar23 Mar24 Mar25 Mar26
EPS (Basic)
0.11 0.47 2.46 3.11

Aptus Pharma Semi-Annual Data
Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
EPS (Basic) Get a 7-Day Free Trial 0.00 1.03 1.42 1.38 1.68
BOM:544529
18GF Score
Aptus Pharma Ltd BOM:544529
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aptus Pharma EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Aptus Pharma's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(46.199-0)/14.845
=3.11

Aptus Pharma's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(28.73-0)/17.142
=1.68

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹3.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹3.06 mean?
Aptus Pharma (BOM:544529) has a EPS (Basic) of ₹3.06 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Aptus Pharma and its competitors.
Is Aptus Pharma's EPS (Basic) too high?
Aptus Pharma's current EPS (Basic) is ₹3.06. Overall, Aptus Pharma has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Aptus Pharma's EPS (Basic) compare to MCK and COR?
Aptus Pharma's EPS (Basic) of ₹3.06 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Distribution company?
A good EPS (Basic) depends on the Medical Distribution industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Aptus Pharma and its competitors. Aptus Pharma's current EPS (Basic) is ₹3.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aptus Pharma stock overvalued right now?
Aptus Pharma (BOM:544529) has a current EPS (Basic) of ₹3.06. The current EPS (Basic) is ₹3.06. Aptus Pharma's overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Aptus Pharma (BOM:544529), the current EPS (Basic) is ₹3.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aptus Pharma Business Description

Address Narayan Nagar, Kalawad Road, SHREE Building, 1st Floor, Opp Satyasai Heart Hospital, Sau Uni Area, Rajkot, GJ, IND, 360005
Aptus Pharma Ltd is engaged in the business of marketing and distribution of finished pharmaceutical formulations. It operates through a contract manufacturing model. The group provides a diverse range of pharmaceutical products catering to various therapeutic categories, including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, anti-diabetic, lipid-lowering, and general wellness products. These are offered across a variety of dosage forms, such as tablets, capsules, softgels, syrups, suspensions, injections, ointments, creams, balms, drops, lotions, vials, powders, gels, and sachets.
18GF Score

Get the complete analysis for BOM:544529

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹278.50
Price